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 Congenital nystagmus (CN) is a common oculomotor dis-
order (frequency of 1/1,500 live births) characterized by bi-
lateral involuntary, periodic, predominantly ocular oscillations.
CN onset typically occurs at birth or within the first few months
of life [1] and occurs secondary to the genetic ocular diseases
such as albinism, achromatopsia, and Leber congenital amau-
rosis (OMIN 204000).
CN can be an idiopathic disease or associated with vari-
ous diseases as a syndrome [2]. The inheritance model is
mainly X-linked idiopathic congenital nystagmus (XLICN),
but autosomal recessive (OMIN 257400) and autosomal domi-
nant (OMIN 164100,608345,193003) forms have been de-
scribed.
Some studies indicated that two disease loci of XLICN
were mapped to Xq26-q27 and Xp11.4- Xp11.3 [1,3]. Recently,
Tarpey et al. [4-6] identified several mutations in FRMD7
(OMIN 300628), a gene localizing to Xq26-q27 and respon-
sible for a major part of XLICN.
In this study, 49 members in a Chinese XLICN family
were recruited and examined. Male affected members were
genotyped with microsatellite markers at FRMD7, and direct
sequencing identified a mutation. Using one female patient,
two carriers, and other family members in this large family
(Figure 1), we assessed the correlation between X-inactiva-
tion pattern and phenotype.
METHODS
Clinical evaluations and DNA specimens:  This study followed
the tenets of the Declaration of Helsinki, and the protocol was
approved by the Ethics Committee at the National Research
Institute for Family Planning. Informed consent was obtained
from all family members participating in this study. The fam-
ily, originating from Shandong province in China, contained
21 affected individuals within a six-generation pedigree (Fig-
ure 2). In total, 49 members in this family were recruited, in-
cluding 15 affected individuals (5 males and 10 females) and
34 unaffected individuals or spouses (Figure 2). Ophthalmolo-
gists confirmed the diagnosis of CN and there was no history
of other ocular or systemic abnormalities in the family. A 5 ml
venous blood sample was drawn into an ethylenediamine
tetraacetic acid (EDTA) sample tube from every subject.
Genotyping and allele-sharing analysis:  Genotyping was
performed as described previously [7]. The primer sequences
were taken from GDB. Allele-sharing analysis was performed
with two microsatellite markers, DXS1047 and DXS691,
which were linked with FRMD7 [4] on five affected males
individuals. The physical locations of DXS1047-FRMD7-
DXS691 are 128.9 Mb, 131.0 Mb, and 135.2 Mb, respectively.
DNA sequencing:  Mutations in FRMD7 (NM_194277)
were screened by direct sequencing. Polymerase chain reac-
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56tion (PCR) products of the 12 exons and flanking intron se-
quences of FRMD7 were sequenced on an ABI A3730 Auto-
mated Sequencer (Applied Biosystem, Foster City, CA) [5].
Denaturing HPLC:  Wave DHPLC (Transgenomic, San
Jose, CA) was used to screen exon 9 of FRMD7 from pa-
tients, carriers, family members, and 400 normal, unrelated,
male individuals. DHPLC was performed according to the
protocols described previously [7] with initial concentrations
of buffer A (0.1 M triethylammonium acetate-TEAA) at 53%
and 47% for buffer B (0.1 M TEAA containing 25% acetoni-
trile) while maintaining the procedure at 58.7 °C.
X-Inactivation assay:  Genomic DNA (1 µg) from a nor-
mal male (III:10, as negative control), two male patients (IV:29
and IV:30, as the positive controls), a female patient (V:20),
and two obligate non-penetrant carriers (III:9 and III:11) was
incubated overnight with and without 1 U HpaII in a total
volume of 20 µl. After a 1:2 dilution with water, 2 µl of the
diluted digest was amplified by PCR to detect the polymor-
phic CAG repeat of the androgen receptor (AR). PCR prod-
ucts were separated on a 6% polyacrylamide denaturing gel
for 1.5 h using constant voltage (600 V) and were subsequently
detected by silver stain.
RESULTS
Clinical data:  In this family, there were nine normal carriers
and 11 affected females (Figure 2), who have a milder pheno-
type than the affected males. All affected individuals had nys-
tagmus in early childhood. Night blindness or photophobia
were not observed in any of the affected individuals in the
family nor were there any incidences of systemic or other ocu-
lar anomalies. The X-linked disease was transmitted from fe-
male carriers/patients to afflicted sons yet there was no evi-
dence of male-to-male transmission in this family.
The proband was a 10-year-old female (V:20, Figure 2).
Her visual acuity was about 20/25. While visual acuity of her
father (36-year-old, IV:29, also affected) is 20/32 (right/left).
Myopia was also identified in her father (right/left, 27.50 mm/
27.20 mm).
Allele-sharing analysis:  Allele-sharing analysis con-
firmed the linkage of the disease in the family with the muta-
tion in FRMD7 (data not shown).
Mutation detection in FRMD7: Sequence analysis re-
vealed a G>T transversion in exon 9 (Figure 3) that caused a
conservative substitution of Cys to Phe at codon 271
(p.C271F). No sequence change was detected in the remain-
ing coding sequence of FRMD7. DHPLC analysis confirmed
this mutation and found the mutation to co-segregate with all
affected individuals and obligate carriers in the family. No
mutation was detected in any of the unaffected male family
members or in any of the 400 normal unrelated male indi-
viduals.
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Figure 1. Analysis of methylation of HpaII sites in the human andro-
gen-receptor locus.  The different alleles at the X androgen-receptor
locus are shown. The upper is the results of DNA without treatment
of HpaII. The bottom shows that only genomic DNA of the female
affected individuals (V:20) and two carriers (III:9 and III:11) were
digested by HpaII. As to affected female (V:20), after digestion, only
an amplified band of AR allele from her mother has been achieved
and she may inherit the mutant allele of FRMD7 on the active X
chromosome (unmethylated) from the father. While, carrier (III:11)
and her sister (III:9, carrier) hold a different active X chromosome.
Affected male individual (IV:29) and his affected brother (IV:31)
inherited different allele on the AR locus from their mother (III:11).
Figure 2. The Chinese X-linked idiopathic congenital nystagmus pedigree.  The squares and circles symbolize males and females, respec-
tively. Dots in the middle of the circle denote that the female is a carrier. Black and white denotes affected and unaffected status, respectively.
An individual is identified (ID) by generation number and the aforementioned symbols. ID underscored with blue indicates individuals
enrolled in this study.
57Multiple-sequence alignment and mutation analysis:
Using the National Center for Biotechnology Information
(NIH) websites, a multiple-sequence alignment of the FRMD7
proteins in various species (Homo sapiens, Canis familiaris,
Mus musculus, Rattus norvegicus, and Gallus gallus) was ob-
tained. This alignment was compared to homologous proteins
(FERM, RhoGEF, FARP2 protein) using DNAMAN
biosoftware (Lynnon Biosoft, Quebec, Canada). The muta-
tion, p.C271F, occurred within a highly conserved region of
the gene. The online bioinformatics software SIFT (Sorting
Intolerant, Tolerant) algorithm [8] predicted whether the amino
acid substitution in FRMD7 would have a phenotypic effect.
The software determined that the substitution of Cys to Phe at
position 271 was deleterious.
The predicted p.C271F substitution represented a conser-
vative amino-acid change with the uncharged polar sulfhy-
dryl side group of Cys replaced by the nonpolar group on Phe.
This change is likely to destabilize the protein by inducing
structural changes by placing a larger amino acid within a re-
stricted space of the protein. Additional changes associated
with losing the free sulfhydryl group may disturb the disul-
fide bond formation between inter- or intra-molecular resi-
dues.
Overall, the cosegregation of the G-T transversion is only
found within the affected and obligate, non-penetrant carriers
in the pedigree. These results suggest that the p.C271F substi-
tution was a causative mutation.
X-Inactivation assay:  Affected female individuals car-
ried the mutated X chromosome. Genes in this affected X chro-
mosome were active and unmethylated because the DNA could
be digested with HpaII (V:20, the allele from her father IV:29
is cut by HpaII). As a result, only methylated DNA on the X
chromosome was used as a PCR template (Figure 1, V:20 and
the allele from her mother, IV:30). The X chromosome from
carrier III:9 was methylated and contained the mutated
FRMD7. Additionally, carrier III:11 had an unmethylated X
chromosome containing the FRMD7 mutation. Take together,
carrier (III:11) and her sister (III:9, carrier) held a different
active X chromosome. Meanwhile, affected male individual
(IV:29) and his affected brother (IV:31) inherited different al-
lele on the AR locus from their mother (III:11).
DISCUSSION
 Congenital nystagmus is a clinically and genetically hetero-
geneous disease that causes visual impairment in childhood.
Clinically, the congenital nystagmus is divided into idiopathic
and nystagmus-related syndromes. Idiopathic congenital nys-
tagmus is thought to represent an abnormal development of
the ocular motor areas of the brain that control fixation. As
these patients may have normal visual acuity, it is presumed
that the nystagmus represents a primary defect in the parts of
the brain responsible for ocular motor control.
Genetically, at least four loci have been proposed for fa-
milial idiopathic congenital nystagmus [1-6,9-12]. Two loci
have been identified for XLICN with one being mapped to
Xq26-q27 by Kerrison and the other to Xp11.4-p11.3 by Cabot
[1,3].
In this family, it was obvious that the trait is X-linked
because there was no male-to-male transmission, but there was
frequent female-to-male transmission. The estimated pen-
etrance among obligate female carriers was estimated to be
55% [11 of 20] with no age dependent affect. The penetrance
in this family is lower than that found in a family studied by
Schorderet and colleagues [5]. The different penetrance in dif-
ferent XLICN families is consistant with previous studies by
Waardenburg. He felt there was no reason to separate an X-
linked recessive from an X-linked dominant form as some have
attempted (OMIM 310700). In some families, the disorder is
recessive in one line and dominant in another. The explana-
tion could be that the mutation is identical, but a series of
“wildtype” isoalleles have different effects on penetrance of
the mutation in the heterozygous female.
Meanwhile, X chromosome inactivation may be one
mechanism for the variation in penetrance. Inactivation is a
methylation-dependent phenomenon and consists of transcrip-
tional silencing of one of the two alleles on X chromosomes
in mammalian females [13]. Most females are mosaics with a
mixture of cells expressing either their mothers or fathers X-
linked genes. Often, cell mosaicism is advantageous by ame-
liorating the deleterious effects of X-linked mutations and
contributing to physiologic diversity [14]. Yet, in some cases,
females carrying the mutant gene have clinical manifestation
as observed in this study.
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Figure 3. DNA sequence chromatograms.  DNA sequence chromato-
grams of the affected members (A), carriers (B), and unaffected mem-
bers (C) in an X-linked idiopathic congenital nystagmus family is
shown. There is a single base G>T transversion in exon 9 of FRMD7
that causes a conservative substitution of Cys to Phe at codon 271
(p.C271F). This mutation co-segregated with all affected individuals
and was present in the obligate, non-penetrant carrier.
58To uncover the correlation between the X-inactivation
pattern and phenotype, we assayed for the pattern in one fe-
male patient, two carriers, and other family members in this
large family. Because the affected IV:29 and IV:31 patients
inherited different alleles of CAG repeats at AR from their
mother (III:11), the results showed that there is at least one
recombination event in these nuclear families. Since physical
distance from the FRMD7 to the AR gene is 64.2 Mb (131.0
Mb, 66.8 Mb for FRMD7, AR, respectively), a marker closer
to the FRMD7 locus is required to assay the methylation sta-
tus of the wild-type and mutant allele.
Carriers III:9 and III:11 showed different methylation pat-
terns for the X chromosome, implying that a molecular basis
for variable methylation might not be involved in the dissimi-
lar penetrance in this family. Female heterozygotes contain
two cell types where the proportion of cells departs from equal-
ity following cell selection at the tissue or organism level [15].
Willemsen et al. [16] reported that monozygotic twin sisters
with the fragile X mutation could have different phenotypes
resulting from skewed X-inactivation. Furthermore, other re-
sults have proven that familial non-random inactivation is
linked to the X-inactivation center in heterozygotes that mani-
fest hemophilia A, one of the inherited blood diseases [17].
While the patterns of X-inactivation in blood may not neces-
sarily reflect those in tissue, the methylation status of FRMD7
in the pathologic tissue could be different from that of blood.
Taken together, no correlation between the X-inactivation pat-
tern and phenotype were observed in blood analyzed in this
study. This finding is consistent with a recent study [18] and
as such, further studies need to investigate the X-inactivation
pattern and phenotype in this family.
Since only two loci have been mapped on the X chromo-
some and the results of genotyping show that the affected in-
dividuals shared the same allele with the FRMD7 locus, we
sequenced the coding and flanking intron sequences of
FRMD7, the only reported gene responsible for XLICN. This
data led us to conclude that the family in this study contains a
novel mutation.
Tarpey et al. [4] identified 22 novel mutations in FRMD7
in 26 families with XLICN. Schorderet et al. [5] identified
five novel mutations in six families with XLICN. Among these
22 mutations, a missense mutation of C271Y in exon 9 was
detected in a Scottish family. In our study, the p.C271F muta-
tion is responsible for this disease. Schorderet et al. [5] identi-
fied another mutation (H275P) in exon 9. These studies sug-
gested that the coding region of exon 9 is critical to the nor-
mal function of the FRMD7 protein.
FRMD7 encodes a member of the FERM-domain (Band
4.1 family) containing proteins. The FERM domain is found
in cytoskeletal-associated proteins such as ezrin, moesin,
radixin, 4.1R, and merlin. Proteins of the FERM-domain family
are thought to be involved in cytoskeleton attachment to the
plasma membrane [19,20]. The mouse genome encodes at least
50 FERM proteins, but the functions of only a few, including
the actin-binding proteins ezrin (also known as Vil2), radixin,
moesin, Nf2 (also known as merlin), and the erythrocyte pro-
tein band 4.1, have been characterized. Therefore, from the
function of these FERM proteins, FRMD7 may have func-
tions relevant to cell structure, cell migration, normal cell
growth, cellular differentiation, and signal transduction.
FRMD7 is expressed in early human embryos at about 56
days post-ovulation in the ventricular layer of the forebrain,
midbrain, cerebellar primordium, spinal cord, and the devel-
oping neural retina [4]. This restricted expression suggests a
specific role in the control of eye movement and gaze stabil-
ity.
This study confirmed that FRMD7 plays an important role
in motor control of eye movement and provided additional
information on gene mutations in exon 9 of FRMD7 that lead
to mutations causing XLICN. Therefore, FRMD7 is an ideal
candidate for XLICN mutation screening. When no mutation
has been identified, it is suggested to scan the whole X chro-
mosome to mapping the responsible gene. While the role of
FRMD7 in disease genesis is still unclear, further studies need
to provide insights into the molecular pathology of XLICN.
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